Companies › ARWR

ARROWHEAD PHARMACEUTICALS IN (ARWR)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000879407 · EDGAR filings · Updated 2026-07-27

ARROWHEAD PHARMACEUTICALS IN (ARWR) has reported institutional ownership of 85.7%, with 432 institutional managers holding positions valued at $7.57B per the latest 13F reporting period.

Filings this week (1)

• 2026-07-27 — SCHEDULE 13G/A filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-06-17 — Insider transaction reported (Form 4)
• 2026-06-17 — Initial insider ownership filed (Form 3)
• 2026-06-16 — Current report (8-K) filed
• 2026-05-19 — 144/A filed
• 2026-05-19 — 144/A filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ARROWHEAD PHARMACEUTICALS IN has 432 institutional holders and institutional ownership of 85.7%.

Insider activity

Insiders reported 90 transactions (0 buys, 67 sells) across 11 reporting insiders, with a net reported value of −$37.5M.

Related companies

KYMERA THERAPEUTICS (KYMR) · HALOZYME THERAPEUTICS INC (HALO) · REPLIGEN CORP COM (RGEN) · KRYSTAL BIOTECH INC (KRYS) · COGENT BIOSCIENCES INC (COGT) · APOGEE THERAPEUTICS INC (APGE)